ABS Direct Equity Fund LLC Takes Position in Teladoc Health, Inc. $TDOC

Key Points

• ABS Direct Equity Fund LLC acquired 178,438 Teladoc shares worth approximately $1.51 million, giving it a 0.10% stake and making TDOC its 27th-largest holding. Institutional investors and hedge funds collectively own 76.82% of the stock.
• Analyst sentiment remains mixed, with five Buy, ten Hold, and one Sell rating. The consensus rating is Hold, with an average price target of $7.54 after several firms revised their targets.
• Teladoc reported a quarterly loss of $0.21 per share, beating estimates, while revenue of $606.93 million fell 4% year over year and missed expectations. Shares opened at $6.11, versus a 52-week range of $4.40 to $9.89.

ABS Direct Equity Fund LLC acquired a new position in shares of Teladoc Health, Inc. (NYSE:TDOC - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 178,438 shares of the health services provider's stock, valued at approximately $1,513,000. Teladoc Health makes up approximately 1.3% of ABS Direct Equity Fund LLC's portfolio, making the stock its 27th biggest holding. ABS Direct Equity Fund LLC owned 0.10% of Teladoc Health at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of the stock. Allworth Financial LP purchased a new stake in shares of Teladoc Health in the 2nd quarter valued at approximately $25,000. Twin Lakes Capital Management LLC purchased a new position in Teladoc Health during the 2nd quarter worth approximately $26,000. Nykredit A S purchased a new position in Teladoc Health during the 2nd quarter worth approximately $27,000. EverSource Wealth Advisors LLC raised its stake in Teladoc Health by 694.5% during the 1st quarter. EverSource Wealth Advisors LLC now owns 5,657 shares of the health services provider's stock valued at $31,000 after purchasing an additional 4,945 shares during the period. Finally, PNC Financial Services Group Inc. raised its stake in Teladoc Health by 177.7% during the 4th quarter. PNC Financial Services Group Inc. now owns 4,391 shares of the health services provider's stock valued at $31,000 after purchasing an additional 2,810 shares during the period. 76.82% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research firms recently weighed in on TDOC. Weiss Ratings reissued a "sell (d-)" rating on shares of Teladoc Health in a research report on Wednesday, August 19th. Citigroup decreased their price objective on Teladoc Health from $11.00 to $7.50 and set a "neutral" rating for the company in a research report on Monday, August 3rd. Canaccord Genuity Group lowered their target price on Teladoc Health from $11.00 to $10.00 and set a "buy" rating on the stock in a research note on Thursday, July 30th. Finally, Bank of America upped their target price on Teladoc Health from $9.00 to $10.50 and gave the company a "buy" rating in a report on Tuesday, July 7th. Five investment analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and an average target price of $7.54.

Teladoc Health Trading Up 0.1%

TDOC opened at $6.11 on Friday. The stock has a fifty day moving average price of $7.57 and a 200 day moving average price of $6.75. Teladoc Health, Inc. has a 1 year low of $4.40 and a 1 year high of $9.89. The stock has a market cap of $1.11 billion, a price-to-earnings ratio of -6.17 and a beta of 2.12.

Teladoc Health (NYSE:TDOC - Get Free Report) last issued its earnings results on Wednesday, July 29th. The health services provider reported ($0.21) earnings per share for the quarter, topping the consensus estimate of ($0.25) by $0.04. Teladoc Health had a negative return on equity of 12.15% and a negative net margin of 7.13%.The company had revenue of $606.93 million for the quarter, compared to analyst estimates of $615.44 million. During the same period in the prior year, the firm posted ($0.19) EPS. The business's revenue was down 4.0% compared to the same quarter last year. Teladoc Health has set its Q3 2026 guidance at -0.300--0.200 EPS and its FY 2026 guidance at -1.000--0.750 EPS. As a group, sell-side analysts forecast that Teladoc Health, Inc. will post -0.89 earnings per share for the current fiscal year.

About Teladoc Health

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc's service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.

Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health, Inc. (NYSE:TDOC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.